ISC 2024 | Should endovascular thrombectomy be used in patients with pre-morbid dementia?

Aravind Ganesh, MD, DPhil, Cumming School of Medicine, University of Calgary, Alberta, Canada, discusses the controversies surrounding the use of reperfusion treatment in stroke patients with premorbid dementia. He acknowledges the challenges healthcare providers face in weighing the risks and benefits of treatment for patients with progressive neurodegenerative conditions like Alzheimer’s disease. Dr Ganesh emphasizes the lack of high-quality evidence regarding the efficacy of thrombectomy in this population due to their exclusion from stroke trials. While observational evidence is limited, he argues that there is no evidence of harm associated with thrombectomy in patients with dementia. However, the question of whether these patients benefit from treatment remains unanswered, underscoring the need for further research in this area. This interview took place during the International Stroke Conference 2024 in Phoenix, AZ
.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.